Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
Article in Orphanet Journal of Rare Diseases (November 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Recurrent erysipelas led to diagnosis of hereditary hemorrhagic telangiectasia.
Article in Infezioni in Medicina (March 2022)
Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination
Article in Haematologica (January 2019)